Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Blood|May 20, 2009
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenLaura A Johnson, Richard A Morgan, Mark E Dudley, et al.Nature|November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M Johannessen, Jesse S Boehm, So Young Kim, et al.Nature|June 1, 2018
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cellsJoseph A Fraietta, Christopher L Nobles, Morgan A Sammons, et al.The Journal of Experimental Medicine|November 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltrationYifan Zhou, Yusra B Medik, Bhakti Patel, et al.NPJ Genomic Medicine|August 19, 2017
Genomic and immune heterogeneity are associated with differential responses to therapy in melanomaAlexandre Reuben, Christine N Spencer, Peter A Prieto, et al.Science (New York, N.Y.)|May 30, 2020
The human tumor microbiome is composed of tumor type-specific intracellular bacteriaDeborah Nejman, Ilana Livyatan, Garold Fuks, et al.Nature|June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapyChristopher P Vellano, Michael G White, Miles C Andrews, et al.Nature Medicine|July 9, 2021
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeMiles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, et al.Science (New York, N.Y.)|December 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.Pageof 3